Skip to content

Willis C Lee, CEO at Emmaus Life Sciences, bought EMMA on May 30, 2025

Prices as of Oct 1 · price update delayed · Every feed →

▲ BUY$1.4K70,000 shares at $0.02Willis C Lee CEOEMMA Emmaus Life Sciences, Inc.
Watch EMMA
Traded
May 30, 2025
Disclosed
Sep 2, 2026
Filed
460 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Willis C Lee, CEO at Emmaus Life Sciences, bought EMMA on May 30, 2025TRADEDDISCLOSED
EMMASimilar stocks (S&P 500 (SPY)), rebased to EMMA's price on the disclosure day
EMMA since disclosure
−8.5%
Similar stocks (SPY) since disclosure
−0.2%
S&P 500 (SPY)

Change in closing price from Sep 2, 2026 (the first trading day on or after disclosure) to Oct 1, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYWillis C Lee CEOEMMA Emmaus Life Sciences, Inc.$5Kdisclosed Sep 2 · filed 2 days after the trade
  2. ▲ BUYWillis C Lee CEOEMMA Emmaus Life Sciences, Inc.$5.7Kdisclosed Sep 2 · filed 5 days after the trade · late
  3. ▲ BUYWillis C Lee CEOEMMA Emmaus Life Sciences, Inc.$2.5Kdisclosed Sep 2 · filed 6 days after the trade · late
  4. ▲ BUYWillis C Lee CEOEMMA Emmaus Life Sciences, Inc.$1.8Kdisclosed Sep 2 · filed 8 days after the trade · late
  5. ▲ BUYWillis C Lee CEOEMMA Emmaus Life Sciences, Inc.$1.7Kdisclosed Sep 2 · filed 369 days after the trade · late

See every trade on EMMA →